Shuttle Pharmaceuticals Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on May 14, 2024, by Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation and emerging growth company. The filing serves as a current report to announce a corporate update issued in connection with the company's Quarterly Report on Form 10-Q for the period ended March 31, 2024.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced Form 10-Q and the attached press release (Exhibit 99.1), which are incorporated by reference but not detailed in this 8-K document.
Material Changes
No specific material changes in financial condition or operations are quantified in this filing. The document solely references the issuance of a press release regarding the Q1 2024 results.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, and specific risk factors are not detailed in the body of this 8-K. The filing notes that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and may only be incorporated by reference in subsequent filings if specifically referenced.
Investor Verification Checklist
- Review the attached Press Release (Exhibit 99.1) for specific Q1 2024 financial results and operational updates.
- Examine the Form 10-Q for the period ended March 31, 2024, for detailed financial statements and cash flow data.
- Verify the company's status as an emerging growth company and its implications for financial reporting standards.
- Confirm the trading symbol (SHPH) and exchange (Nasdaq) for current market data.